Rockefeller Capital Management
MEDP icon

Rockefeller Capital Management’s Medpace MEDP Stock Holding History

Rockefeller Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Sell
309
-86
-22% -$39.7K ﹤0.01% 2708
2026
Q1 		$190K Sell
395
-35
-8% -$17.9K ﹤0.01% 2532
2025
Q4 		$242K Sell
430
-345
-45% -$196K ﹤0.01% 2261
2025
Q3 		$398K Buy
+775
New +$338K ﹤0.01% 1884
2023
Q1 		– Sell
-143
Closed -$30K – 3120
2022
Q4 		$30K Buy
143
+112
+361% +$22.4K ﹤0.01% 2633
2022
Q3 		$4K Sell
31
-41
-57% -$6.54K ﹤0.01% 3411
2022
Q2 		$10K Buy
72
+27
+60% +$3.91K ﹤0.01% 3125
2022
Q1 		$7K Buy
45
+27
+150% +$4.45K ﹤0.01% 3225
2021
Q4 		$3K Buy
18
+4
+29% +$838 ﹤0.01% 3442
2021
Q3 		$2K Sell
14
-4
-22% -$730 ﹤0.01% 3451
2021
Q2 		$3K Buy
18
+6
+50% +$1.04K ﹤0.01% 3170
2021
Q1 		$1K Sell
12
-7
-37% -$1.07K ﹤0.01% 3186
2020
Q4 		$2K Buy
19
+11
+138% +$1.39K ﹤0.01% 2649
2020
Q3 		$0 Buy
+8
New +$925 ﹤0.01% 2699

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Rockefeller Capital Management's MEDP Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Medpace (MEDP) stake by 22% in Q2 2026, selling an estimated $39.7K and leaving 309 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #2708.

Rockefeller Capital Management first reported a position in MEDP in Q3 2020 and has held it in 14 quarters since. The position peaked at $398K in Q3 2025. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Rockefeller Capital Management held 309 shares of Medpace worth $164K as of Q2 2026.
  • Rockefeller Capital Management sold 86 Medpace shares in Q2 2026, an estimated $39.7K.
  • Medpace made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2708 holding.
  • Rockefeller Capital Management first reported a position in Medpace in Q3 2020 and has held it in 14 quarters since.
  • Rockefeller Capital Management's Medpace position peaked at $398K in Q3 2025.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.